| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
58,750,000 |
| Market
Cap: |
28.08(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.355 - $0.478 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sio Gene Therapies is a a clinical-stage company focused on developing gene therapies for neurodegenerative diseases. Co. has three clinical-stage programs: AXO-AAV-GM1 for the treatment of GM1 gangliosidosis; AXO-AAV-GM2 for the treatment of GM2 gangliosidosis (including Tay-Sachs and Sandhoff diseases); and AXO-Lenti-PD for the treatment of Parkinson's disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Roivant Sciences Ltd. |
10% Owner |
– – • |
2019-03-18 |
4 |
B |
$1.50 |
$10,000,001 |
D/D |
6,666,667 |
105,952,381 |
2.45 |
- |
|
| Machado Clarence Patrick |
10% Owner |
– – • |
2019-03-18 |
4 |
B |
$1.50 |
$10,000,001 |
I/I |
6,666,667 |
105,952,381 |
1.5 |
- |
|
| Svf Holdings (uk) Llp |
10% Owner |
– – • |
2019-03-18 |
4 |
B |
$1.50 |
$10,000,001 |
I/I |
6,666,667 |
105,952,381 |
1.5 |
- |
|
| Oren Dan |
10% Owner |
– – • |
2019-03-18 |
4 |
B |
$1.50 |
$10,000,001 |
I/I |
6,666,667 |
105,952,381 |
1.5 |
- |
|
| Lo Andrew |
10% Owner |
– – • |
2019-03-18 |
4 |
B |
$1.50 |
$10,000,001 |
I/I |
6,666,667 |
105,952,381 |
1.5 |
- |
|
| Roivant Sciences Ltd. |
10% Owner |
– – • |
2018-12-18 |
4 |
B |
$1.00 |
$10,000,000 |
D/D |
10,000,000 |
99,285,714 |
2.45 |
- |
|
| Machado Clarence Patrick |
10% Owner |
– – • |
2018-12-18 |
4 |
B |
$1.00 |
$10,000,000 |
I/I |
10,000,000 |
99,285,714 |
1.5 |
- |
|
| Qvt Offshore Ltd. |
10% Owner |
– – • |
2018-12-18 |
4 |
B |
$1.00 |
$10,000,000 |
I/I |
10,000,000 |
99,285,714 |
1.5 |
- |
|
| Shabet Rose Sharon |
10% Owner |
– – • |
2018-12-18 |
4 |
B |
$1.00 |
$10,000,000 |
I/I |
10,000,000 |
99,285,714 |
1.5 |
- |
|
| Lo Andrew |
10% Owner |
– – • |
2018-12-18 |
4 |
B |
$1.00 |
$10,000,000 |
I/I |
10,000,000 |
99,285,714 |
1.5 |
- |
|
| Oren Dan |
10% Owner |
– – • |
2018-12-18 |
4 |
B |
$1.00 |
$10,000,000 |
I/I |
10,000,000 |
99,285,714 |
1.5 |
- |
|
| Svf Holdings (uk) Llp |
10% Owner |
– – • |
2018-12-18 |
4 |
B |
$1.00 |
$10,000,000 |
I/I |
10,000,000 |
99,285,714 |
1.5 |
- |
|
| Bickerstaff George |
Director |
– • – |
2018-08-09 |
4 |
B |
$2.07 |
$51,750 |
D/D |
25,000 |
50,000 |
2.39 |
- |
|
| Lo Andrew |
10% Owner |
– – • |
2018-06-05 |
4 |
B |
$1.75 |
$25,000,000 |
I/I |
14,285,714 |
89,285,714 |
1.5 |
- |
|
| Qvt Fund V Lp |
10% Owner |
– – • |
2018-06-05 |
4 |
B |
$1.75 |
$25,000,000 |
I/I |
14,285,714 |
89,285,714 |
1.5 |
- |
|
| Oren Dan |
10% Owner |
– – • |
2018-06-05 |
4 |
B |
$1.75 |
$25,000,000 |
I/I |
14,285,714 |
89,285,714 |
1.5 |
- |
|
| Softbank Vision Fund L.p. |
10% Owner |
– – • |
2018-06-05 |
4 |
B |
$1.75 |
$25,000,000 |
I/I |
14,285,714 |
89,285,714 |
1.5 |
- |
|
| Shabet Rose Sharon |
10% Owner |
– – • |
2018-06-05 |
4 |
B |
$1.75 |
$25,000,000 |
I/I |
14,285,714 |
89,285,714 |
1.5 |
- |
|
| Viking Long Fund Gp Llc |
10% Owner |
– – • |
2018-06-05 |
4 |
B |
$1.75 |
$25,000,000 |
I/I |
14,285,714 |
89,285,714 |
1.5 |
- |
|
| Machado Clarence Patrick |
10% Owner |
– – • |
2018-06-05 |
4 |
B |
$1.75 |
$25,000,000 |
I/I |
14,285,714 |
89,285,714 |
1.5 |
- |
|
| Roivant Sciences Ltd. |
10% Owner |
– – • |
2018-06-05 |
4 |
B |
$1.75 |
$25,000,000 |
D/D |
14,285,714 |
89,285,714 |
2.45 |
- |
|
| Bickerstaff George |
Director |
– • – |
2018-02-27 |
4 |
B |
$1.50 |
$37,425 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
| Modig Berndt |
Director |
– • – |
2017-12-29 |
4 |
OE |
$0.90 |
$70,123 |
D/D |
77,914 |
77,914 |
|
- |
|
| Shabet Rose Sharon |
10% Owner |
– – • |
2017-07-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
75,000,000 |
|
- |
|
| Hung David |
Principal Executive Officer |
• • – |
2017-04-17 |
4 |
B |
$18.54 |
$10,000,013 |
D/D |
539,375 |
539,375 |
2.81 |
- |
|
64 Records found
|
|
Page 2 of 3 |
|
|
